Zimmer Biomet Holdings, Inc. (ZBH)
After hours:
| Previous close | 120.65 |
| Open | 120.20 |
| Bid | 118.00 x 800 |
| Ask | 125.00 x 800 |
| Day's range | 119.21 - 120.69 |
| 52-week range | 105.31 - 165.03 |
| Volume | |
| Avg. volume | 1,569,731 |
| Market cap | 25.114B |
| Beta (5Y monthly) | 1.16 |
| PE ratio (TTM) | 115.33 |
| EPS (TTM) | 1.04 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | 0.96 (0.80%) |
| Ex-dividend date | 24 Jun 2022 |
| 1y target est | 131.55 |
- Simply Wall St.
Are Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Mixed Financials Driving The Negative Sentiment?
With its stock down 4.8% over the past three months, it is easy to disregard Zimmer Biomet Holdings (NYSE:ZBH). We...
- Zacks
Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
- GlobeNewswire
Akerna Announces Financial Results for First Quarter 2022
Software revenue up 71%, total revenue up 73% year-over-yearDENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today reported its unaudited financial results for the quarter ended March 31, 2022. "As demand for Akerna’s platforms from cannabis operators, regulators, and brands continues to widen, we
